ホーム>>8,12-iso-iPF2α-VI-1,5-lactone

8,12-iso-iPF2α-VI-1,5-lactone

カタログ番号GC41137

F2-イソプロスタン(F2-iPs)は、リン脂質に結合したアラキドン酸の自由基媒介過酸化反応から生じると考えられています。

Products are for research use only. Not for human use. We do not sell to patients.

8,12-iso-iPF2α-VI-1,5-lactone 化学構造

サイズ 価格 在庫数 個数
25μg
$161.00
在庫あり
50μg
$307.00
在庫あり
100μg
$579.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

F2 isoprostanes (F2-iPs) are thought to arise from the free radical-mediated peroxidation of phospholipid-bound arachidonic acid. They are cleaved, presumably by an unidentified phospholipase A2, and are found in the circulation and the urine. 8,12-iso-iPF2α-VI-1,5-lactone is a racemic mixture of the lactone forms of the free acid, 8,12-iso- iPF2α-VI. Previously called IPF2α -I, the free acid form, iPF2α-VI, is the most abundant F2-iP regioisomer measured in the urine of rats treated with CCl4 to induce lipid peroxidation. iPF2α-VI is the only regioisomer that undergoes lactonization, and this occurs slowly in vivo or can be driven chemically. The less polar lactone is readily separated from the free acid forms of iPF2α. While the level of iPF2α-VI in plasma, urine and organs is used as a biomarker for oxidative stress, some F2-iPs also evoke significant biological effects. It is not known if 8,12-iso-iPF2α-VI-1,5-lactone has important physiological effects.

レビュー

Review for 8,12-iso-iPF2α-VI-1,5-lactone

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 8,12-iso-iPF2α-VI-1,5-lactone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.